Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
120M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
13.3M
-
Shares change
-
-870K
-
Total reported value, excl. options
-
$42.2M
-
Value change
-
-$3.52M
-
Number of buys
-
15
-
Number of sells
-
-21
-
Price
-
$3.18
Significant Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q3 2019
42 filings reported holding AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value as of Q3 2019.
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
of 120M outstanding shares and own 11.04% of the company stock.
Largest 10 shareholders include Bratton Capital Management, L.P. (11.5M shares), BlackRock Inc. (371K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (294K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (121K shares), JACOBS LEVY EQUITY MANAGEMENT, INC (114K shares), JPMORGAN CHASE & CO (112K shares), MILLENNIUM MANAGEMENT LLC (100K shares), BAKER BROS. ADVISORS LP (99.6K shares), WEDBUSH SECURITIES INC (98.5K shares), and OXFORD ASSET MANAGEMENT LLP (72.3K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.